The FDA has authorized the launch of an early-stage trial testing a CAR T-cell therapy for people with hard-to-treat ...
People whose dietary habits are more in line with a Mediterranean-style diet may be less likely to develop multiple sclerosis ...
Ottawa, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The global multiple sclerosis (MS) diagnosis and treatment market size was valued at USD 22.14 billion in 2023 and is predicted to hit around USD 28.48 ...
Multiple Sclerosis Explained: Symptoms, Risk Factors & How It’s Treated MONDAY, Nov. 10, 2025 (HealthDay News) — Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the ...
Key opinion leaders discuss the single FDA-approved option for primary progressive multiple sclerosis and emerging therapies under investigation for this MS subtype, examine the PERSEUS trial, and ...
Patients suffering from multiple sclerosis (MS), a chronic neurological disorder that primarily affects young adults and can ...
The National Institute for Health and Care Excellence (NICE) has updated its guidance on the use of cladribine (Mavenclad, Merck) for patients with rapidly evolving severe relapsing-remitting multiple ...
Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million people estimated to be living with the disease worldwide. As MS is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results